
Dr. Alexander Wiseman MD
Development Chair,
American Society of Transplantation
Visit the partner pages below to see the full range of offerings
Resource Library
No items matching filters
Comparing the Functionality of Both Cytogam & Cytotect CP CMV-HIG Preparations to 2 IVIg Preparations
Antiviral Effect of Cytomegalovirus Immune Globulin after Liver Transplantation in Patients who were not CMV Donor Positive/Recipient Negative. Jennifer K.L. Chow, MD, MS, FAST; Laura A. McDermott, BS; David R. Snydman, MD, FAST. Tufts Medical Center, Boston, MA.
Post-transplant kidney recipient monitoring has dramatically changed in the last few years. The addition of gene expression profiling with TruGraf kidney and ddcfDNA assessment augmented with infectious disease tracking with TRAC provides clinicians with cutting edge tools. But what happens when these two tests disagree with one another? The Chair of the Department of Transplantation and Liver Surgery at Geisinger Health System and a Professor of Surgery at Geisinger Commonwealth School of Medicine.
Watch this on-demand webinar where we'll explore the significance of TTV in clinical settings and its potential as an objective aid for modifying immunosuppression in transplant recipients. Discover the latest diagnostic tools and methodologies that utilize TTV, along with real-world examples showcasing its impact on patient outcomes. The session will also include an interactive Q&A. Don't miss this opportunity to enhance your understanding of TTV in transplant care!
Join us for an insightful presentation by Dr. Luis Ostrosky-Zeichner, MD, where we explore the latest advancements and emerging trends in the field of medical mycology. The discussion covers critical topics such as current epidemiological data, evolving nomenclature standards, and recent innovations in antifungal treatments. Additionally, the video delves into the necessity for new diagnostic methods to keep pace with novel drugs and examines the evolving practices in clinical trial conduct. Join us for a comprehensive update on where medical mycology stands today and what the future holds.
Transplant Genomics is proud to announce the release of OmniGraf™ Liver, the first and only non-invasive diagnostic test that provides guidance for controlled reduction of immunosuppression to optimize therapy in liver transplant recipients. This innovative test provides a score for patients to assess their risk of rejection. OmniGraf™ Liver grades a patient on their risk for rejection, providing a numerical output for patients at high or low risk inclusive of patients that match the phenotype of acute dysfunction of the liver without the presence of rejection. Utilizing molecular biomarkers and advanced bioinformatics, OmniGraf™ Liver also allows for the controlled reduction of immunosuppressant therapy in three easy steps. OmniGraf™ Liver features a negative predictive value of 93%, internally validated using patient data from the CTOT-14 trial.
Watch this important webinar on Treating Subclinical Rejection featuring Dr. John Friedewald, Dr. Michael Marvin, and Dr. Namita Singh, as they delve into the complexities of treating subclinical rejection in kidney transplantation. This webinar offers a unique opportunity to gain insights from a panel of experts who bring a wealth of knowledge and experience to the table. Together, they will explore the latest advancements in identifying and managing subclinical rejection, drawing from their combined expertise in both research and clinical practice.
Eurofins Transplant revolutionizes transplant testing, offering breakthrough solutions that empower both patients and providers alike. Comprising five key divisions within Eurofins: CellTX, Donor & Product Testing, Ascend Clinical, Viracor, and Transplant Genomics, these organizations collectively influence every critical stage in the transplant journey.
Explore case studies featuring CMV inSIGHT™ T Cell Immunity testing.
Molecular Biomarkers Guide Treatment and Prevent Rejection in Graft Monitoring
Identifying HRS-AKI earlier starts with CARE. The key to having better treatment success starts with earlier diagnosis. Mallinckrodt is excited to offer a handy tool to help spot the symptoms of hepatorenal syndrome–acute kidney (HRS-AKI) faster.
In this debut episode, we are thrilled to have Dr. Zahraa Hajjiri from UIC as our featured guest. Dr. Hajjiri will be discussing the important and complex topic of Delayed Graft Function, shedding light on its causes, challenges, and approaches to management using Tutivia.
Sanofi is committed to partnering with the transplant community in recognizing and addressing issues that may contribute to disparities in transplantation and driving equity in health care through the education of patients and providers.
Disparities Appear Throughout the Kidney Transplant Patient Journey
Sanofi is proud to support initiatives that amplify the value of transplant programs for hospitals and health care systems, and help improve efficiencies in living donor programs.